Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
posted on
Jul 08, 2019 09:28AM
According to previous PR, they have cash until July?
How are they going to deal with that?
“If the Offering is completed, it is expected that the net proceeds of the Offering, together with the Corporation’s available cash, will only be sufficient to fund operating activities until July 31, 2019. The Corporation will need to raise additional capital to remain in compliance with covenants applicable to its Secured Loan (as defined herein), to repay the balance of the Secured Loan at the maturity date of August 4, 2019 and to fund continued operations beyond that time period."